Similar title :
INOVIO starts developing the Omicron-specific COVID vaccine candidate
INOVIO announces strategy against Omicron known (B .1.1.529) and future SARS-CoV-2 variants
INOVIO for testing its COVID-19 vaccine candidates against the Omicron variant – Brief info
Inovio Pharma (INO) announces strategy to combat Omicron (B.1.1.529) and future SARS-CoV-2 variants

Ref: https://seekingalpha.com